Mumbai, Jan. 29 -- Indegene today announced that Jill DeSimone, a widely respected global life sciences leader, and Neeraj Bharadwaj, a renowned private equity leader, have joined Indegene's Board of Directors.

Jill brings over four decades of life sciences leadership, with hands-on experience building and leading large commercial and medical organizations. She has held senior leadership roles at leading biopharma

companies, including President of U.S. Oncology at Merck, where she led major businesses and product franchises across global markets. She led the launch of Keytruda, Merck's first true oncology product. Jill

has also held leadership roles at Teva and Bristol Myers Squibb. She currently serves on the Boards of several public ...